References
1. Mendes C, Costa J, Vicente AA, Oliveira MBPP, Mafra I. Cashew Nut
Allergy: Clinical Relevance and Allergen Characterisation. Clin
Rev Allergy Immunol . 2019;57(1):1-22. doi:10.1007/s12016-016-8580-5
2. Johnson J, Malinovschi A, Alving K, Lidholm J, Borres MP, Nordvall L.
Ten-year review reveals changing trends and severity of allergic
reactions to nuts and other foods. Acta Paediatr Int J Paediatr .
2014;103(8). doi:10.1111/apa.12687
3. McWilliam V, Koplin J, Lodge C, Tang M, Dharmage S, Allen K. The
Prevalence of Tree Nut Allergy: A Systematic Review. Curr Allergy
Asthma Rep . 2015;15(54). doi:10.1007/s11882-015-0555-8
4. Crealey M, Alamin S, Tormey V, Moylett E. Clinical presentation of
cashew nut allergy in a paediatric cohort attending an allergy clinic in
the West of Ireland. Ir J Med Sci . 2019;188:219-222.
doi:10.1007/s11845-018-1801-6
5. Clark AT, Anagnostou K, Ewan PW. Cashew nut causes more severe
reactions than peanut: Case-matched comparison in 141 children.Allergy . 2007;62(8):913-916. doi:10.1111/j.1398-9995.2007.01447.x
6. Wang J, Sampson HA. Safety and efficacy of epicutaneous immunotherapy
for food allergy. Pediatr Allergy Immunol . 2018;29(4):341-349.
doi:10.1111/pai.12869
7. Mondoulet L, Dioszeghy V, Thébault C, Benhamou PH, Dupont C.
Epicutaneous immunotherapy for food allergy as a novel pathway for oral
tolerance induction. Immunotherapy . 2015;7(12).
doi:10.2217/imt.15.86
8. Mondoulet L, Dioszeghy V, Puteaux E, et al. Intact skin and not
stripped skin is crucial for the safety and efficacy of peanut
epicutaneous immunotherapy (EPIT) in mice. Clin Transl Allergy .
2012;2(22). doi:10.1186/2045-7022-2-22
9. Hervé P-L, Dhelft V, Plaquet C, et al. Epidermal micro-perforation
potentiates the efficacy of epicutaneous vaccination. J Control
Release . 2019;298:12-26. doi:10.1016/j.jconrel.2019.02.004
10. Mattison CP, Malveira Cavalcante J, Izabel Gallão M, Sousa de Brito
E. Effects of industrial cashew nut processing on anacardic acid content
and allergen recognition by IgE. Food Chem . 2018;240:370-376.
doi:10.1016/j.foodchem.2017.07.146
11. Mattison CP, Bren-Mattison Y, Vant-Hull B, Vargas AM, Wasserman RL,
Grimm CC. Heat-induced alterations in cashew allergen solubility and IgE
binding. Toxicol Reports . 2016;3:244-251.
doi:10.1016/j.toxrep.2015.12.009
12. Brough HA, Liu AH, Sicherer S, et al. Atopic dermatitis increases
the effect of exposure to peanut antigen in dust on peanut sensitization
and likely peanut allergy. J Allergy Clin Immunol . 2015;135(1).
doi:10.1016/j.jaci.2014.10.007
13. Finkelman FD. Anaphylaxis: Lessons from mouse models. J
Allergy Clin Immunol . 2007;120(3):506-515.
doi:10.1016/j.jaci.2007.07.033
14. Dioszeghy V, Mondoulet L, Laoubi L, et al. Antigen uptake by
Langerhans cells is required for the induction of regulatory T cells and
the acquisition of tolerance during epicutaneous immunotherapy in
OVA-sensitized mice. Front Immunol . 2018;9(1951).
doi:10.3389/fimmu.2018.01951
15. Tordesillas L, Lozano-Ojalvo D, Dunkin D, et al. PDL2+ CD11b+ dermal
dendritic cells capture topical antigen through hair follicles to prime
LAP+ Tregs. Nat Commun . 2018;9(1). doi:10.1038/s41467-018-07716-7
16. Pereira MA, Rebouças J de S, Ferraz-Carvalho R de S, et al.
Poly(anhydride) nanoparticles containing cashew nut proteins can induce
a strong Th1 and Treg immune response after oral administration.Eur J Pharm Biopharm . 2018;127:51-60.
doi:10.1016/j.ejpb.2018.02.011
17. Sampson HA, Shreffler WG, Yang WH, et al. Effect of varying doses of
epicutaneous immunotherapy vs placebo on reaction to peanut protein
exposure among patients with peanut sensitivity: A randomized clinical
trial. JAMA - J Am Med Assoc . 2017;318(18):1798-1809.
doi:10.1001/jama.2017.16591
18. van de Veen W, Akdis M. Role of IgG4 in IgE-mediated allergic
responses. J Allergy Clin Immunol . 2016;138(5):1434-1435.
doi:10.1016/j.jaci.2016.07.022
19. Snapper CM, Paul WE. Interferon-γ and B cell stimulatory factor-1
reciprocally regulate Ig isotype production. Science (80- ) .
1987;236(4804):944-947. doi:10.1126/science.3107127
20. Romagnani S. Immunologic influences on allergy and the TH1/TH2
balance. J Allergy Clin Immunol . 2004;113(3):395-400.
doi:10.1016/j.jaci.2003.11.025
21. Galli SJ, Tsai M. IgE and mast cells in allergic disease. Nat
Med . 2012;18(5):693-704. doi:10.1038/nm.2755
22. Mayr SI, Zuberi RI, Liu FT. Role of immunoglobulin E and mast cells
in murine models of asthma. Brazilian J Med Biol Res .
2003;36(7):821-827. doi:10.1590/S0100-879X2003000700001
23. van Halteren AGS, van der Cammen MJF, Biewenga J, Savelkoul HFJ,
Kraal G. IgE and mast cell responses on intestinal allergen exposure: A
murine model to study the onset of flood allergy. J Allergy Clin
Immunol . 1997;99(1):94-99. doi:10.1016/S0091-6749(97)70305-1
24. Gladys Ang WX, Church AM, Kulis M, Choi HW, Wesley Burks A, Abraham
SN. Mast cell desensitization inhibits calcium flux and aberrantly
remodels actin. J Clin Invest . 2016;126(11):4103-4118.
doi:10.1172/JCI87492
25. Oka T, Rios EJ, Tsai M, Kalesnikoff J, Galli SJ. Rapid
desensitization induces internalization of antigen-specific IgE on mouse
mast cells. J Allergy Clin Immunol . 2013;132(4):922-932.
doi:10.1016/j.jaci.2013.05.004
26. Dioszeghy V, Mondoulet L, Puteaux E, et al. Differences in
phenotype, homing properties and suppressive activities of regulatory T
cells induced by epicutaneous, oral or sublingual immunotherapy in mice
sensitized to peanut. Cell Mol Immunol . 2017;14(9):770-782.
doi:10.1038/cmi.2016.14
27. Tordesillas L, Mondoulet L, Blazquez AB, Benhamou PH, Sampson HA,
Berin MC. Epicutaneous immunotherapy induces gastrointestinal LAP+
regulatory T cells and prevents food-induced anaphylaxis. J
Allergy Clin Immunol . 2017;139(1):189-201.
doi:10.1016/j.jaci.2016.03.057
28. Kim EH, Burks AW. Food allergy immunotherapy: OIT and EPIT.Allergy . Published online 2020.
doi:https://doi.org/10.1111/all.14220
29. Bastiaan-Net S, Reitsma M, Cordewener JHG, et al. IgE
Cross-Reactivity of Cashew Nut Allergens. Int Arch Allergy
Immunol . 2019;178(1):19-32. doi:10.1159/000493100